Unichem Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.87×	0.86×	0.89×	1.14×	1.15×
	3.33×	4.95×	1.10×	4.75×	1.11×
	4.6%	2.7%	6.6%	−0.8%	−11.8%
	0.60×	0.60×	0.63×	0.54×	0.41×
	1.38×	1.38×	1.46×	1.34×	1.31×
	10.9%	9.5%	6.0%	−3.0%	−8.1%
	9.8%	9.8%	5.7%	−2.9%	−8.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

UNICHEMLAB₹488.80

Unichem Laboratories Limited

· Pharma & Health

₹ CrorePeersGUFICBIO RPGLIFE GUJTHEM SMSPHARMA ORCHPHARMA INDSWFTLAB SOLARA FDCMcap ₹3,441 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	1.15	1.14	0.89	0.86	0.87
Interest Burden (Pretax/EBIT) ×	1.11	4.75	1.10	4.95	3.33
EBIT Margin %	-11.84	-0.76	6.65	2.68	4.56
Asset Turnover ×	0.41	0.54	0.63	0.60	0.60
Financial Leverage (Assets/Equity) ×	1.31	1.34	1.46	1.38	1.38
ROE (5-step product, year-end total equity) %	-8.09	-2.99	5.98	9.48	10.90
ROE (owners' profit / average owners' equity) %	-8.00	-2.94	5.71	9.78	9.78

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.